Nicholas Zolnerowich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nicholas Zolnerowich has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- André Nussenzweig
Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
1 shared publication - Bruno Di Stefano
Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, USA
1 shared publication Dali Zong
Laboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA
1 shared publication- Dongpeng Wang
Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, USA
1 shared publication - Elsa Callen
Laboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA
1 shared publication - Ferenc Livak
Laboratory of Genome Integrity, Flow Cytometry Core, Center for Cancer Research, National Cancer Institute, National Institutes of Health
1 shared publication
Latest Publications
- 2 December 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6623) , 983-989
Active DNA demethylation promotes cell fate specification and the DNA damage response
Neurons harbor high levels of single-strand DNA breaks (SSBs) that are targeted to neuronal enhancers, but the source of this endogenous damage remains unclear. Using two systems of postmitotic lineage specification—induced pluripotent stem cell–derived neurons and transdifferentiated macrophages—we show that thymidine DNA glycosylase (TDG)–driven excision of methylcytosines oxidized with ten-eleven translocation enzymes (TET) is a source of SSBs. Although macrophage differentiation favors short-patch base excision repair to fill in single-nucleotide gaps, neurons also frequently use the long-patch subpathway. Disrupting this gap-filling process using anti-neoplastic cytosine analogs triggers a DNA damage response and neuronal cell death, which is dependent on TDG. Thus, TET-mediated active DNA demethylation promotes endogenous DNA damage, a process that normally safeguards cell identity but can also provoke neurotoxicity after anticancer treatments.
- 2 December 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6623) , 983-989
Active DNA demethylation promotes cell fate specification and the DNA damage response
Neurons harbor high levels of single-strand DNA breaks (SSBs) that are targeted to neuronal enhancers, but the source of this endogenous damage remains unclear. Using two systems of postmitotic lineage specification—induced pluripotent stem cell–derived neurons and transdifferentiated macrophages—we show that thymidine DNA glycosylase (TDG)–driven excision of methylcytosines oxidized with ten-eleven translocation enzymes (TET) is a source of SSBs. Although macrophage differentiation favors short-patch base excision repair to fill in single-nucleotide gaps, neurons also frequently use the long-patch subpathway. Disrupting this gap-filling process using anti-neoplastic cytosine analogs triggers a DNA damage response and neuronal cell death, which is dependent on TDG. Thus, TET-mediated active DNA demethylation promotes endogenous DNA damage, a process that normally safeguards cell identity but can also provoke neurotoxicity after anticancer treatments.